Concepedia

A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer

Mace L. Rothenberg, Malcolm J. Moore, M. Christine Cripps, John Sahl Andersen, Russell K. Portenoy, H.A. Burriss, M.R. Green, Peter G. Tarassoff, T.D. Brown, E. S. Casper,

Annals of Oncology · 1996 · 569 citations · 10 references

DOIFull text

Open access

Concepts

References

10

Evaluation of the antitumor activity of gemcitabine (2',2'-difluoro-2'-deoxycytidine).

Larry W. Hertel, G B Boder, Julian S. Kroin et al. · PubMed · 1990 · 683 citations

, , +11

Comparison of the cellular pharmacokinetics and toxicity of 2',2'-difluorodeoxycytidine and 1-beta-D-arabinofuranosylcytosine.

Volker Heinemann, Larry W. Hertel, Gerald B. Grindey et al. · PubMed · 1988 · 509 citations

, , +13

Phase II trial of gemcitabine (2,2′-difiuorodeoxycytidine) in patients with adenocarcinoma of the pancreas

Ephraim S. Casper, Mark R. Green, David P. Kelsen et al. · Investigational New Drugs · 1994 · 441 citations

, , +11

Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2',2'-difluorodeoxycytidine.

Volker Heinemann, Yi-Zheng Xu, Sherri Chubb et al. · Molecular Pharmacology · 1990 · 407 citations

, , +13

The memorial pain assessment card. A valid instrument for the evaluation of cancer pain

Baruch Fishman, Sara Pasternak, Stanley L. Wallenstein et al. · Cancer · 1987 · 331 citations · Full text

, , +16